THRB and acute myeloid leukemia: Differential TRBV gene usage was driven by multiple genes, with TRBV12-3, TRBV5-7, and TRBV6-9 being significantly overrepresented in the group of AML patients with a broadened TRB repertoire after AZA (Supplemental Fig. 11).